Indagine sulle modalità operative dell’analisi delle crioproteine: dalla fase preanalitica alla refertazione
Survey on cryoproteins testing among Italian Laboratories: from pre-analytical phase to reporting

AUTORI

ABSTRACT

Survey on cryoproteins testing among Italian Laboratories: from pre-analytical phase to reporting

Introduction: cryoproteinemia is associated with a broad spectrum of clinical symptoms and significant variability among patients; in this context, laboratory diagnostics play a crucial role in diagnosis and treatment. However, diagnosing cryoglobulinemia is difficult from a clinical point of view and in the laboratory. SIBioC (Italian Society of Clinical Biochemistry and Molecular Biology) has proposed a survey to the Italian laboratories to assess the adopted methods.
Methods: the survey consisted of 40 questions: 8 concerning general items, 9 on the pre-analytical phase, 14 on the analytical phase, 4 on the post-analytical phase, and 5 on the cryofibrinogen.
Results: sixty-six laboratories responded to the survey, mainly from Northern Italy. The results show non-homogeneous situation. Preanalytical phase: some laboratories are not equipped with adequate devices for transporting the sample maintaining a temperature-controlled chain. Analytical phase: not all laboratories apply the same procedures to separate the serum, to wash the cryo-precipitate and to measure the cryocrit. Postanalytical phase: almost all laboratories apply the Brouet classification. 11% of laboratories perform cryofibrinogen testing, 20% participate in an external quality assessment, and 62% of participants feel the need for an adequate scientific information and training.
Conclusions: the survey shows that the procedures for cryoprotein testing vary widely among laboratories. The need of recommendations emerges strongly; these could start from the existing literature in the field, the already available procedures, trying make a synthesis where the processes are diversified. It is also crucial to participate to External Quality Assessment and to spread the culture of continuous dialogue with clinicians.

BIBLIOGRAFIA

1. Brouet J-C, Clauvel J-P, Danon F, Klein M, Seligmann M. Biological and clinical significance of cryoglobulins. Am J Med 1974;57:775-88.
2. Kolopp-Sarda M, Miossec P. Pratical details for detection and interpretation of cryoglobulins. Clin Chem 2022;68:282-90.
3. Napodano C, Gulli F, Rapaccini GL, Marino M, Basile U. Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins. Adv Clin Chem 2021;104:299-340.
4. Saadoun D, Musset L, Cacoub P. Les cryofibrinogénémies. Rev Med Interne 2011;32:287-91.
5. Moiseev S, Luqmani R, Novikov P, Shevtsova T. Cryofibrinogenaemia-a neglected disease. Rheumatology (Oxford) 2017;56:1445-51.
6. Michaud M, Pourrat J. Cryofibrinogenemia. J Clin Rheumatol 2013;19:142-8.
7. Smith SB, Arkin C. Cryofibrinogenemia: Incidence, Clinical Correlations, and a Review of the Literature. Am J Clin Pathol 1972;58:524-30.
8. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N. Cryoglobulinemia-A clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966;40:837-56.
9. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis 2008;3:25.
10. Quartuccio L, Isola M, Corazza L, Ramos-Casals M, Retamozo S, Ragab GM et al. Validation of the classification criteria for cryoglobulinaemic vasculitis. Rheumatology 2014;53:2209-13.
11. Monti G, Galli M, Invernizzi F, Pioltelli P, Saccardo F, Monteverde A et al. Cryoglobulinaemias: GISC. Italian Group for the Study of Cryoglobulinaemias. QJM 1995;88:115-26.
12. De Vita S, Soldano F, Isola M, Monti G, Gabrielli A, Tzioufas A et al. Preliminary classification criteria for the cryoglobulinaemic vasculitis. Ann Rheum Dis 2011;70:1183-90.
13. Natali P, Debbia D, Sheldon J, Bari A, Basile U, Lavatelli F et al. Diagnosi di crioproteinemia: preziosa collaborazione tra laboratorio e clinica per la corretta gestione di una patologia rara. Biochim Clin 2022;46:166-75.
14. Debbia D, Campioli D, Turra F, Frattolillo D, Peruzzi S, Chiodino C et al. Le criticità della fase post-analitica della determinazione delle crioglobuline: risultati di uno studio pilota condotto in Emilia-Romagna. Biochim Clin 2021;45:388-94.
15. Passerini G, Basile U. Recommendations for a protocol to detect, quantify and characterize cryoglobulins. Biochim Clin 2010;34:218-22.
16. Kolopp-Sarda MN, Miossec P. Cryoglobulins: An update on detection, mechanisms and clinical contribution. Autoimmun Rev 2018;17:457-64.
17. Musset L, Diemert MC, Taibi F, Thi Huong Du L, Cacoub P, Leger JM. Characterization of cryoglobulins by immunoblotting. Clin Chem 1992;38:798-802.
18. Dolci A. Crioglobuline: Un esame da raccomandare “caldamente.” Biochim Clin 2010;34:169-70.
19. Napodano C, Gulli F, Ludovico G, Mariapaola M, Umberto B. Cryoglobulins: identification, classification, and novel biomarkers of mysterious proteins. Adv Clin Che 2021;104:299-340.
20. Bhandari J, Awais M, Aeddula NR. Cryoglobulinemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing 2022: p 1–7. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557606/ (ultimo accesso: febbraio 2023).
21. Mariscal-Rodríguez A, Guimerans LMV, López-Trascasa M, Hernández González M, E Moga Naranjo 5; en nombre del grupo de inmunoquímica de la Sociedad Española de Inmunología. Laboratory guidelines for the diagnosis of patients with cryoglobulinemic syndrome. Rev Clin Esp (Barc) 2019:219:505-13.
22. Sargur R, White P, Egner W. Review Article Cryoglobulin evaluation: best practice? Ann Clin Biochem 2010;47:8-17.
23. Natali P, Debbia D, Cucinelli MR, Trenti T, Amati G, Spinelli A, et al. Analysis of cryoproteins with a focus on cryofi brinogen: a study on 103 patients. Chin Chem Lab Med 2022;60:1796-803.
24. Desbois AC, Cacoub P, Saadoun D. Cryoglobulinemia: An update in 2019. Jt Bone Spine 2019;86:707-13.
25. Trendelenburg M, Schifferli JA. Cryoglobulins are not essential. Ann Rheum Dis 1998;57:3-5.
26. Galli M, Oreni L, Saccardo F, Castelnovo L, Filippini D, Marson P et al. HCV-unrelated cryoglobulinaemic vasculitis: The results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC). Clin Exp Rheumatol 2017;35:67-76.
27. Mazzaro C, Dal Maso L, Mauro E, Visentini M, Tonizzo M, Gattei V et al. Hepatitis C virus-related cryoglobulinemic vasculitis: A review of the role of the new direct antiviral agents (DAAs) therapy. Autoimmun Rev 2020;19:102589.
28. Gragnani L, Lorini S, Marri S, Basile U, Santarlasci V, Monti M et al. Hematological and genetic markers in the rational approach to patients with HCV sustained virological response with or without persisting cryoglobulinemic vasculitis. Hepatology 2021;7:1164-73.
29. Natali P, Debbia D, Trenti T, Galassi G, Chester J, Sandri G et al. Frequency and results of cryoglobulin retesting in 4,963 patients: Comment on the article by Kolopp-Sarda et al. Arthritis Rheumatol 2020;72:1955-6.
30. Kolopp-Sarda MN, Nombel A, Miossec P. Cryoglobulins today: detection and immunologic characteristics of 1,675 positive samples from 13,439 patients obtained over six years. Arthritis Rheumatol 2019;71:1904-12.
31. Smith R. A heparin-precipitable fraction of human plasma. II. Occurrence and significance of the fraction in normal individuals and in various disease states. J Clin Investig 1957;36:605-16.
32. Smith R, Von Korff R. A Heparin-precipitate fraction of human plasma. I. Isolation and characterization of the fraction. J Clin Investig 1956;36:596-604.